Last Price$62.00.0%
Market Cap$5,745.5M
LTM Cash & Cash Equivalents
$34.3M
YoY Growth
+15.5%
3Y CAGR
-2.9%
5Y CAGR
+2.2%
Stock quality & Intrinsic value
6/10
15.1% overvalued
Stericycle, Inc. Cash & Cash Equivalents
Annual
Quarterly
LTM
Crunching data... Almost there!
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $7,850.0K | $7,825.0K | $13.5M | $17.1M | $9,095.0K | $15.8M | $77.1M | $22.5M | $31.3M | $62.0M | $22.2M | $55.6M | $44.2M | $42.2M | $34.3M | $34.7M | $53.3M | $55.6M | $56.0M | $35.3M |
Overvalued or undervalued?
Check the intrinsic value for SRCL
and see if it's the right time to invest.
Stericycle, Inc. (SRCL) Cash & Cash Equivalents comparison analysis
General
LTM Cash & Cash Equivalents
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
Stericycle, Inc.SRCL
$34.3M
15.5%
(2.9%)
2.2%
Median Peer Set
$84.5M
(20.2%)
8.5%
8.8%
Waste Management, Inc.WM
$5,381.0M
1,074.9%
257.3%
8.6%
Clean Harbors, Inc.CLH
$687.2M
54.5%
14.9%
13.1%
Casella Waste Systems, Inc.CWST
$383.3M
73.5%
124.6%
156.2%
GFL Environmental Inc.GFL
$93.0M
(9.2%)
(11.1%)
(25.3%)
Enviri CorporationNVRI
$88.4M
(29.1%)
2.1%
9.1%
Ambipar Emergency ResponseAMBI
$80.7M
(20.3%)
N/A
N/A
Republic Services, Inc.RSG
$74.0M
(47.1%)
36.7%
9.5%
Waste Connections, Inc.WCN
$62.4M
(20.0%)
(24.9%)
(28.2%)
LanzaTech Global, Inc.LNZA
$58.7M
(35.7%)
326.3%
N/A
Montrose Environmental Group, Inc.MEG
$12.9M
(44.3%)
(55.4%)
15.1%
SRCL key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 516.2 0.0% | 609.5 18.1% | 789.6 29.6% | 932.8 18.1% | 1,083.7 16.2% | 1,177.7 8.7% | 1,439.4 22.2% | 1,676.0 16.4% | 1,913.1 14.1% | 2,142.8 12.0% | 2,555.6 19.3% | 2,985.9 16.8% | 3,562.3 19.3% | 3,580.7 0.5% | 3,485.9 (2.6%) | 3,308.9 (5.1%) | 2,675.5 (19.1%) | 2,646.9 (1.1%) | 2,704.7 2.2% | 2,659.3 (1.7%) |
| Cost of Goods Sold (COGS) | 288.0 | 341.4 | 439.8 | 514.8 | 598.7 | 625.3 | 772.0 | 915.3 | 1,055.8 | 1,178.2 | 1,461.2 | 1,779.4 | 2,059.1 | 2,118.2 | 2,109.9 | 2,134.4 | 1,622.4 | 1,629.7 | 1,679.1 | 1,655.6 |
% margin | 228.2 44.2% | 268.0 44.0% | 349.9 44.3% | 417.9 44.8% | 485.0 44.8% | 552.4 46.9% | 667.4 46.4% | 760.7 45.4% | 857.3 44.8% | 964.6 45.0% | 1,094.4 42.8% | 1,206.5 40.4% | 1,503.2 42.2% | 1,462.5 40.8% | 1,376.0 39.5% | 1,174.5 35.5% | 1,053.1 39.4% | 1,017.2 38.4% | 1,025.6 37.9% | 1,003.7 37.7% |
| Operating Expenses | 81.8 | 99.7 | 144.7 | 192.1 | 203.7 | 227.9 | 275.4 | 316.7 | 358.8 | 410.5 | 482.0 | 605.7 | 1,064.1 | 1,470.1 | 1,178.4 | 1,055.1 | 897.6 | 946.6 | 887.5 | 926.4 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, General & Administrative Expenses (SG&A) | 80.6 | 98.0 | 144.4 | 176.7 | 199.2 | 222.5 | 268.4 | 291.8 | 327.1 | 372.1 | 433.9 | 539.9 | 1,029.4 | 1,470.1 | 1,178.4 | 1,055.1 | 897.6 | 946.6 | 887.5 | 707.4 |
% margin | 145.7 28.2% | 168.4 27.6% | 201.8 25.6% | 224.5 24.1% | 274.2 25.3% | 315.2 26.8% | 370.7 25.8% | 424.3 25.3% | 468.8 24.5% | 535.6 25.0% | 556.3 21.8% | 487.6 16.3% | 439.1 12.3% | (7.6) (0.2%) | (161.1) (4.6%) | 109.9 3.3% | 149.5 5.6% | 72.3 2.7% | 153.7 5.7% | 77.3 2.9% |
| Interest Income | 0.0 | 0.8 | 1.4 | 1.6 | 0.9 | 0.3 | 0.3 | 0.8 | 0.4 | 0.3 | 0.1 | 0.2 | 0.1 | 0.3 | 0.6 | 118.3 | 81.9 | 71.9 | 75.5 | 0.0 |
| Interest Expense | 0.0 | 13.0 | 28.4 | 34.0 | 33.1 | 34.4 | 37.1 | 49.4 | 51.7 | 54.9 | 66.0 | 77.3 | 97.7 | 93.7 | 106.0 | 118.3 | 81.9 | 71.9 | 75.5 | 73.9 |
| Pre-tax Income | 128.6 | 112.0 | 172.6 | 191.2 | 239.0 | 277.7 | 331.9 | 372.3 | 417.2 | 477.7 | 487.6 | 410.9 | 333.8 | (107.9) | (275.4) | (362.8) | (56.0) | 0.7 | 78.9 | 3.3 |
% effective tax rate | 50.4 39.2% | 44.8 40.0% | 67.3 39.0% | 72.9 38.1% | 90.3 37.8% | 101.3 36.5% | 121.4 36.6% | 135.0 36.3% | 147.3 35.3% | 164.7 34.5% | 159.4 32.7% | 142.9 34.8% | 126.3 37.8% | (150.9) 139.9% | (29.8) 10.8% | (16.8) 4.6% | (0.1) 0.2% | 27.5 3,928.6% | 22.4 28.4% | 24.6 745.5% |
% margin | 78.2 15.1% | 67.2 11.0% | 105.3 13.3% | 118.4 12.7% | 148.7 13.7% | 175.7 14.9% | 207.9 14.4% | 234.8 14.0% | 268.0 14.0% | 311.4 14.5% | 326.5 12.8% | 267.1 8.9% | 206.0 5.8% | 42.4 1.2% | (244.7) (7.0%) | (346.0) (10.5%) | (55.9) (2.1%) | (26.8) (1.0%) | 56.0 2.1% | (21.4) (0.8%) |
| EPS | 0.89 | 0.76 | 1.19 | 1.35 | 1.74 | 2.03 | 2.39 | 2.77 | 3.12 | 3.64 | 3.85 | 3.01 | 2.09 | 0.27 | (2.81) | (3.80) | (0.61) | (0.29) | 0.61 | (0.23) |
| Diluted EPS | 0.85 | 0.74 | 1.16 | 1.32 | 1.68 | 2.03 | 2.39 | 2.69 | 3.08 | 3.56 | 3.79 | 2.96 | 2.08 | 0.27 | (2.81) | (3.80) | (0.61) | (0.29) | 0.61 | (0.23) |
% margin | 161.6 31.3% | 189.8 31.1% | 228.0 28.9% | 256.3 27.5% | 306.3 28.3% | 352.0 29.9% | 422.8 29.4% | 488.1 29.1% | 545.2 28.5% | 634.3 29.6% | 717.0 28.1% | 615.8 20.6% | 678.5 19.0% | 235.6 6.6% | 84.4 2.4% | 24.7 0.7% | 427.9 16.0% | 394.4 14.9% | 413.0 15.3% | 293.7 11.0% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Stericycle, Inc.'s Cash & Cash Equivalents?
As of today, Stericycle, Inc.'s last 12-month Cash & Cash Equivalents is $34.3M, based on the financial report for Sep 30, 2024 (Q3’2024).
2) What is Stericycle, Inc.'s Cash & Cash Equivalents growth rate?
Over the last year, Stericycle, Inc.'s Cash & Cash Equivalents growth was 15.5%. The average annual Cash & Cash Equivalents growth rates for Stericycle, Inc. have been (11.8%) over the past three years, 2.2% over the past five years.
3) Is Stericycle, Inc.'s Cash & Cash Equivalents growth rate Good?
Over the last year, Stericycle, Inc.'s Cash & Cash Equivalents growth was 15.5%, which is higher than industry growth of (0.5%). It indicates that Stericycle, Inc.'s Cash & Cash Equivalents growth is Good.